Clinical Trials Directory

Trials / Conditions / Recurrent Childhood Malignant Germ Cell Tumor

Recurrent Childhood Malignant Germ Cell Tumor

10 registered clinical trials studyying Recurrent Childhood Malignant Germ Cell Tumor.

StatusTrialSponsorPhase
Active Not RecruitingErdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or H
NCT03210714
National Cancer Institute (NCI)Phase 2
CompletedOlaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Hist
NCT03233204
National Cancer Institute (NCI)Phase 2
CompletedAlisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
NCT01154816
Children's Oncology GroupPhase 2
CompletedVorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Cent
NCT00994500
National Cancer Institute (NCI)Phase 1
CompletedCombination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
NCT00467051
Children's Oncology GroupPhase 2
CompletedBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagn
NCT00638898
City of Hope Medical CenterPhase 1
CompletedOxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
NCT00101270
National Cancer Institute (NCI)Phase 1
CompletedOxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatme
NCT00091182
National Cancer Institute (NCI)Phase 2
CompletedErlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors
NCT00077454
National Cancer Institute (NCI)Phase 1
CompletedFlavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
NCT00012181
National Cancer Institute (NCI)Phase 1